The Importance of Recency of Cancer Diagnosis in Patients Hospitalized with COVID-19-Glimpses from an EHR-based Study.
Cancer Epidemiol Biomarkers Prev
; 32(1): 3-5, 2023 01 09.
Article
in English
| MEDLINE | ID: covidwho-2194258
ABSTRACT
Multiple prior studies have shown an increased risk of severe disease and death from SARS-CoV-2 infection in patients with cancer. Nolan and colleagues conducted a multi-institution, electronic health record (EHR)-based study of adults hospitalized with COVID-19 delineating the difference in outcomes when stratified by current versus former cancer diagnosis and found that only a current diagnosis appears to confer an increased risk of severe COVID-19 and death.We review these findings in the context of other studies examining outcomes for individuals with cancer diagnoses and COVID-19. We also address questions raised by this type of study about the significant challenges of EHR-based studies and discuss potential avenues for future research in this arena. See related article by Nolan et al., p. 12.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Neoplasms
Type of study:
Diagnostic study
/
Prognostic study
Limits:
Adult
/
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Cancer Epidemiol Biomarkers Prev
Journal subject:
Biochemistry
/
Epidemiology
/
Neoplasms
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS